DALE Pharma
0791.839.803 · rovalta.com · 24/09/2026
DALE Pharma
Company — Opening of bankruptcy.
Financial year 2023 · Closed on 31/12/2023
Overview
Identity
Source · BCE/KBODALE Pharma is a Private limited company incorporated in 2022. Its main activity is: Retail sale in non-specialised stores. Its registered office is in Enghien. It employs on average 17,6 ETP workers (FTE).
- Legal situation
- Opening of bankruptcy
- BCE/KBO no. / VAT
- BE 0791.839.803
- Incorporation
- 04/10/2022
- Legal form
- Private limited company
- Registered office
- Grand Place(E) 50
7850 Enghien · WallonieSee on map - Contributed capital
- 605 297,00 €
- Latest accounts
- 31/12/2023
- Average workforce
- 17,6 ETP
Financials
Source · NBB, 1 filingTrend over 1 financial year
| 2023 | |
|---|---|
| Income statement | |
| Revenue | 3,3 M € |
| EBITDA | 94,6 k € |
| Operating result | 44,2 k € |
| Net result | 716 € |
| Balance sheet | |
| Equity | 606 k € |
| Total assets | 3,1 M € |
| Cash | 33,6 k € |
| Debts | 2,5 M € |
| Other | |
| Workforce | 17,6 ETP |
Board of directors
Source · NBB, accounts to 31/12/20231 active
Active mandates
Other companies at this address
Grand Place(E) 50 7850 Enghien| Company | CBE no. |
|---|---|
AG-fix-IT● Active | 0776.507.269 |
BOLIDES & COMPAGNIE● Active | 1027.047.183 |
BYGHY CONSTRUCT● Bankrupt | 0670.495.474 |
EGOMATIC● Active | 0837.724.464 |
FEEL I.T.● Active | 0476.743.716 |
FIGRA● Active | 0890.248.281 |
MG Vision● Active | 1030.950.939 |
NJ-INNOVATION● Active | 1001.721.968 |
OPTICAL QUALITY PRIORITY● Active | 1026.636.716 |
PROJET DRISHTI● Active | 1038.875.542 |
SynergyWorks● Active | 1016.572.272 |
The Mug Enghien● Active | 0676.565.595 |
V2v CONSTRUCT● Liquidation | 0790.569.893 |
Financials
Full financial information
Source · NBB| 2023 | |
|---|---|
| Type of account | Abridged model |
| Start of the financial year | 01/10/2022 |
| Closing of the financial year | 31/12/2023 |
| Length of the financial year | 15 months |
| Filing date | 15/08/2024 |
| General meeting | 15/06/2024 |
| Currency of the financial year | EUR |
| NBB quality label | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 1 filing| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2023 | 15/06/2024 | 15/08/2024 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20231 active
Active mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Registered office12/09/2024SIEGE SOCIAL
- Mandates08/03/2024DEMISSIONS, NOMINATIONS
- Other22/02/2024STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Capital / shares01/08/2023STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
- Registered office14/03/2023SIEGE SOCIAL
- Mandates22/02/2023DEMISSIONS, NOMINATIONS
- Other06/10/2022RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2023Annual accounts 2023716 €
- 04/10/2022IncorporationPrivate limited company